Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction

Journal of Clinical Psychiatry

Volumn 66, Issue 3, 2005, Pages 346-352

  O'Connor, Christopher M ^a   Glassman, Alexander H ^b   Harrison, David J ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SERTRALINE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DATA ANALYSIS; DEPRESSION; DIAGNOSIS RELATED GROUP; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 16444366903     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0311     Document Type: Article

References (42)

1. Blazer G, Kessler RC, McGonagle KA, et al. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994;151:979-986
2. Jonsson B, Bebbington PE. What price depression? the cost of depression and cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994;163:665-673
3. Simon G, Ormel J, Von Korff M, et al. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995;152:352-357
4. Manning W, Wells K. The effects of psychological distress and psychological well-being on use of medical services. Med Care 1992;30:541-553
5. Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405-419
6. Frasure-Smith N, Lesperance F, Gravel G, et al. Depression and health-care costs during the first year following myocardial infarction. J Psychosom Res 2000;48:471-478
7. Levine JB, Covino VA, Slack WV, et al. Psychological predictors of subsequent medical care among patients hospitalized with cardiac disease. J Cardiopulm Rehabil 1996;16:109-116
8. Lesperance F, Frasure-Smith N, Juneau M, et al. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000;160:1354-1360
9. Ariyo AA, Haan M, Tangen CM, et al, for the Cardiovascular Health Study Collaborative Research Group. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation 2000;102:1773-1779
10. Schulz R, Beach SR, Ives DG, et al. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 2000;160:1761-1768
11. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996;93:1976-1980
12. Braunwald E, Amman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina und non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000;36:970-1062
13. Carney RM, Rich MW, Freedland KE, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988;50:627-633
14. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999-1005
15. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989;149:1785-1789
16. Koenig HG. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry 1998;20:29-43
17. Forrester AW, Lipsey JR, Teitelbaum ML, et al. Depression following myocardial infarction: effects of depression and anxiety. Psychosom Med 2001;63:221-230
18. Croghan TW, Obenchain RL, Crown WE. What does treatment of depression really cost? Health Aff (Millwood) 1998;17:198-208
19. Hylan TR, Crown WH, Meneades L, et al. Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis. J Affect Disord 1998;47:71-79
20. Frank L, Revicki DA. Sorensen SV, et al. The economics of selective serotonin reuptake inhibitors in depression: a critical review. CNS Drugs 2001;15:59-83
21. Sclar DA, Robison LM, Skaer TL, et al. Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization. Clin Ther 1994;16:715-729
22. Simon GE, Manning WG, Katzelnick DJ, et al. Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. Arch Gen Psychiatry 2001;58:181-187
23. Schoenbaum M, Unutzer J, Sherboume C, et al. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA 2001;286:1325-1330
24. Sullivan M, Simon G, Sperms J, et al. Depression-related costs in heart failure care. Arch Intern Med 2002;162:1860-1866
25. Wong WM, Lam KF, Cheung C, et al. Population based study of non-cardiac chest pain in southern Chinese: prevalence, psychosocial factors, and healthcare utilization. World J Gastroenterol 2004;14:707-712
26. Ziegelstein RC, Fauerbach JA, Stevens SS, et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000;160:1818-1823
27. Glassman AH, O'Connor CM, Califf R, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-709
28. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976
29. Prospective Payment System's (PPS) Final Notice for Fiscal Year. The DRG relative weights, geometric and arithmetic mean length of stay. Federal Register 2002 May 9;67:31618-31627
30. Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
31. Ades PA, Pashkow FJ, Nestor JR. Cost-effectiveness of cardiac rehabilitation after myocardial infarction. J Cardiopulm Rehabil 1997;17:222-231
32. Mintz J, Mintz LI, Arruda MJ, et al. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992;49:761-768
33. Kupersmith J, Holmes-Rovner M, Hogan A, et al. Cost-effectiveness analysis in heart disease, pt 3: ischemia, congestive heart failure, and arrhythmias. Prog Cardiovasc Dis 1995;37:307-346
34. Franzosi MG, Maggioni AP, Santoro E, et al. Cost-effectiveness analysis of early lisinopril use in patients with acute myocardial infarction. Pharmacoeconomics 1998;13:337-346
35. Sherman DL, Ryan TJ. Coronary angioplasty versus bypass grafting: cost-benefit considerations. Med Clin North Am 1995;79:1085-1095
36. Elliot WJ, Weir DR. Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarction. Am J Health Syst Pharm 1999;56:1726-1732
37. Hlatky MA. Analysis of costs associated with CABG and PTCA. Ann Thorac Surg 1996;61:S30-S32
38. Sloan F. Valuing Health Care. New York, NY: Cambridge University Press; 1996
39. Peterson ED, Cowper PA, DeLong ER, et al. Acute and long-term cost implications of coronary stenting. J Am Coll Cardiol 1999;33:1610-1618
40. Mahoney EM, Jurkovitz CT, Chu H, et al. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA 2002;288:1851-1858
41. Johannesson M, Jonsson G, Kjekshus J, et al. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. N Engl J Med 1997;336:332-336
42. Phillips KA, Shlipak MG, Coxson P, et al. Health and economic benefits of increased [beta]-blocker use following myocardial infarction. JAMA 2000;284:2748-2754